Wall Street analysts weigh in on AI leaders and tech giants
Analysts are split on the future of Anthropic and SpaceX while updating ratings for major players like Apple, Netflix, and Tesla.
The short version
- Seaport issued a neutral rating on Anthropic, citing concerns over slowing revenue growth in Q3.
- Oppenheimer raised its Amazon price target to $310 to account for the value of its ownership stake in Anthropic.
- Morgan Stanley reiterated an overweight rating on SpaceX, arguing that the market is underestimating Starlink's value.
- UBS reported that wait times for Apple's Duo declined by ~21 days WoW to ~53 days on average.
Why it matters
These ratings reflect how big money is pricing the 'AI boom' versus actual revenue performance. For the average reader, it shows that while AI is a major theme, investors are becoming more selective about which companies can turn that technology into sustainable profit.
The AI Valuation Debate
Wall Street is currently grappling with how to value the rapid rise of artificial intelligence. Seaport initiated coverage on Anthropic with a neutral rating, suggesting that investors should wait to buy the stock later. The firm expressed concern that Anthropic's revenue growth slowed sharply in Q3 and might not see significant improvement in the fourth quarter.
To justify its current valuation, the firm believes Anthropic will need to demonstrate much higher growth rates over the next two years. Seaport noted that if the company truly is the greatest company ever, there will be plenty of time for investors to enter the market at a later date. This cautious stance highlights a growing trend of looking past the hype to find concrete financial milestones.
In contrast, William Blair initiated coverage on Anthropic with an outperform rating. While acknowledging that the risks are real, the firm argued that investors should not miss the forest for the trees. They view AI as a revolutionary technology and see Anthropic at the forefront of developing and commercializing frontier models in a nascent market.
Amazon's Strategic Stake
Amazon's position in the AI landscape is receiving specific attention from analysts following Anthropic's IPO. Oppenheimer raised its price target for Amazon to $310, up from $285. This move was designed to reflect the specific value of the ownership stake Amazon holds in Anthropic.
The analysis assumes a full conversion of all Anthropic securities held by Amazon. At a price of $97 per share, the ~3.5B shares held by Amazon are estimated to be worth about $339B. This valuation represents a significant portion of the company's overall market narrative.
Oppenheimer applied a 15% holding-company discount to the gross value of that stake when calculating the new price target. This calculation adds ~$25/share to the existing $285 valuation, reflecting a 15% holding-company discount to the stake's gross value. It shows how investors are now quantifying the value of private AI partnerships as part of public company worth.
SpaceX and Starlink Outlook
Morgan Stanley reiterated an overweight rating on SpaceX, focusing heavily on the value of its Starlink satellite network. The firm argues that the market does not fully appreciate the value of providing high bandwidth connectivity to robots. These robots utilize self-contained AI inference compute, power, cooling, locomotion, actuation, and telephony to perform useful work at scale.
Meanwhile, HSBC updated its rating on Tesla to hold from reduce, citing confusion over the potential merger between Tesla and SpaceX. The firm stated that the strategic logic for such a merger is not immediately apparent. They suggested that the move might be motivated by a desire for control rather than clear operational synergy.
HSBC also noted that a merger could make access to capital harder for the companies involved. The firm's analysis suggests that the equity narrative is shifting toward the potential acquisition price. This highlights the complexity of evaluating companies that are increasingly looking to merge their aerospace and automotive technologies.
Tech and Retail Trends
Apple is seeing some positive movement in its hardware availability, according to UBS. The firm reiterated a neutral rating but noted that wait times for the Duo are declining. Data from the UBS Evidence Lab shows that wait times across 30+ geographies dropped by ~21 days WoW to ~53 days on average.
In the streaming space, Bernstein reiterated an outperform rating for Netflix. The firm believes Netflix can achieve double-digit growth by the end of the year. However, they noted that the debate over the durability of Netflix's moat is getting louder as competitors invest more heavily in content.
Bernstein highlighted that whether Netflix can deliver 'double-digit' revenue growth in 2027 is a legitimate question given the current deceleration. They suggested that pricing will likely need to do much of the work to reach those targets. This reflects a broader market concern about how streaming giants can maintain growth as the market becomes more saturated.
Broad Market Shifts
Several other companies saw rating changes based on improved visibility or marketing strategies. Truist upgraded Evolent to a buy rating, noting that visibility into 2027 has improved. The firm expects $150 mln+ of EBITDA to become increasingly achievable, leading to an unchanged price target of $6.
Macquarie upgraded PDD Holdings to outperform, citing a prudent marketing strategy despite macro headwinds. They noted that Temu showed clearer signs of approaching profitability. This suggests that even in a difficult macro environment, specific marketing tactics can lead to positive analyst sentiment.
On the healthcare side, TD Cowen upgraded both UnitedHealth and Humana to buy ratings. They see a credible path toward mid-high-teens EPS growth for UnitedHealth through 2028. For Humana, they see a clear path toward a meaningful step-up in 2027 EPS growth and > $40 EPS in 2028.
What to watch
- Whether Anthropic's revenue growth improves in Q4.
- The final outcome of the potential Tesla and SpaceX merger.
- How Amazon's Anthropic stake valuation impacts its long-term price target.
Sources and links
- ReportingCNBC: the article we sourced
First reported by CNBC. Written by the SI Agent News Desk from the reporting above.Written with AI from the source above. Every number is checked against the source. Spot a mistake? Corrections.
Liked it? Say why
Add a line for other readers.
No account needed. We never show your email. Comments with links, ads or abuse are held and not shown. Your comment shows after a quick check.